Mosquito-Borne West Nile Virus Soared in 2018, According to CDC Data

Severe cases of West Nile virus were 25% more common than usual in 2018, and transmission patterns appeared to shift to new regions, according to a new report from the Centers for Disease Control and Prevention (CDC). West Nile is a mosquito-borne virus that is usually asymptomatic, but causes side effects including fever, body aches, vomiting, diarrhea and joint pain in about 20% of people who are infected. In serious cases, it can lead to complications including brain inflammation and meningitis. It is by far the most common mosquito- or tick-borne virus in the U.S.—especially in 2018, according to the CDC’s data. More than 2,600 West Nile diagnoses were recorded in 2018—more than any year in the prior decade except 2012, when more than 5,000 cases were reported. The vast majority of cases were contracted during the summer, and 63% of cases progressed to include neurologic symptoms, a 25% increase over the average from 2008 to 2017. Nationwide, 167 people died from the disease in 2018. California had the most cases of any state, at 154, but the CDC notes that diagnoses were less common than usual there and in other Western states, including Arizona. Meanwhile, states in the mid-Atlantic—including New Jersey, New York and Pennsylvania—reported more cases than usual. An Alaska resident even tested positive for West Nile for the first time, though the CDC says the patient likely picked it up elsewhere. The Midwest reported the highest case counts...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Infectious Disease onetime Source Type: news

Related Links:

ConclusionHemiplegic spontaneous cervical EDH occurs very rarely. It is often misdiagnosed as ischemic stroke and is likely to be administered with thrombolytic agents, making the patient's symptoms worse. Early diagnosis and rapid management of cervical EDH increase the likelihood of complete recovery of the patient's symptoms. Therefore, if there are unilateral weakness and neck pain without cranial nerve dysfunction and there is no evidence of stroke in the brain imaging, spinal EDH should be considered.
Source: Interdisciplinary Neurosurgery - Category: Neurosurgery Source Type: research
We describe the case of a 37-year-old man with a 20-year history of psoriatic arthritis. The patient presented with abdominal pain, watery diarrhea with mild hematochezia, and a reported 24-pound unintentional weight loss over the past five months. Of note, the patient began treatment with etanercept five months earlier after discontinuation of infliximab for his psoriatic arthritis symptoms. Colonoscopy with terminal ileum intubation revealed active colitis and intestinal biopsy results showed marked ulcerations and non-caseating granulomas, indicative of CD. Etanercept was subsequently discontinued and the patient was st...
Source: Journal of Drugs in Dermatology - Category: Dermatology Tags: J Drugs Dermatol Source Type: research
Authors: Alexis AF, Rendon M, Silverberg JI, Pariser DM, Lockshin B, Griffiths CE, Weisman J, Wollenberg A, Chen Z, Davis JD, Li M, Eckert L, Gadkari A, Shumel B, Rossi AB, Graham NM, Ardeleanu M Abstract Dupilumab, a monoclonal antibody that blocks the shared receptor subunit for interleukin (IL)-4 and IL-13, is currently approved for the treatment of adults with inadequately controlled moderate-to-severe atopic dermatitis (AD). The efficacy and safety of dupilumab for AD among racial subgroups is unknown. This post hoc analysis from three phase 3 trials assessed the efficacy and safety of dupilumab vs placebo by ...
Source: Journal of Drugs in Dermatology - Category: Dermatology Tags: J Drugs Dermatol Source Type: research
Authors: Green LJ, Yamauchi PS, Kircik LH Abstract Psoriasis (PsO) is a common, systemic, chronic inflammatory disease characterized by key clinical symptoms, including itching, pain, and scaling, and is associated with substantial physical, psychosocial, and economic health burdens. Currently, there is no cure for PsO; however, the introduction of biologic therapies has revolutionized the clinical management of patients with PsO by expanding treatment options to include multiple therapies with different mechanisms of action targeting cytokines, including tumor necrosis factor inhibitors (TNFis), interleukin (IL)-1...
Source: Journal of Drugs in Dermatology - Category: Dermatology Tags: J Drugs Dermatol Source Type: research
ConclusionDifferent from current algorithms, our technique focuses on a particular problem in the field of speech pathology detection (SPD), not yet explored in detail, proposing a way to successfully solve it. Furthermore, the results we obtained stimulate broaden studies involving speech data inconsistencies whilst providing a valid contribution.
Source: Biomedical Signal Processing and Control - Category: Biomedical Science Source Type: research
Anyone else using these ALTO guidelines for non opioid pain management in your ED? We have a non opioid pain policy with big banners in the ED informing patients and although physicians are technically free to order whatever they think is appropriate, we get emails with the names of physicians who are the biggest offenders with ordering narcotics in the ER so there is definitely pressure to not order them if you can help it. FMD is 100% behind the push for no opioids. At first, I was really... ALTO....sounds like a muppet character
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Emergency Medicine Source Type: forums
Conclusion: The clinical presentation and risk factors of scabies change significantly with scabies outbreaks, and consequently so do the lines of treatment in Saudi Arabia. The present study highlights the importance of adopting strategies related to community infection control and prevention. PMID: 31423520 [PubMed - in process]
Source: Saudi Medical Journal - Category: Middle East Health Tags: Saudi Med J Source Type: research
Condition:   Postoperative Pain Interventions:   Drug: Piroxicam group;   Drug: Placebo Sponsor:   Ain Shams University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Pain, Acute;   Preterm Infant;   Breast Milk Interventions:   Other: Olfactive stimulation intervention with familiarization;   Other: Olfactive stimulation intervention;   Other: Standard care Sponsor:   St. Justine's Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Substance Use Disorders;   Pain Intervention:   Behavioral: SBIRT-PM Sponsors:   Yale University;   National Center for Complementary and Integrative Health (NCCIH);   National Institute on Drug Abuse (NIDA);   US Department of Veterans Affairs Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acticin | Babies | Brain | Centers for Disease Control and Prevention (CDC) | Health | Infectious Diseases | Men | Meningitis | Neurology | Pain | Tickborne Diseases | West Nile Virus